Abstract:Marine sponges are currently one of the richest sources of pharmacologically active compounds found in the marine environment. These bioactive molecules are often secondary metabolites, whose main function is to enable and/or modulate cellular communication and defense. They are usually produced by functional enzyme clusters in sponges and/or their associated symbiotic microorganisms. Natural product lead compounds from sponges have often been found to be promising pharmaceutical agents. Several of them have successfully been approved as antiviral agents for clinical use or have been advanced to the late stages of clinical trials. Most of these drugs are used for the treatment of human immunodeficiency virus (HIV) and herpes simplex virus (HSV). The most important antiviral lead of marine origin reported thus far is nucleoside Ara-A (vidarabine) isolated from sponge Tethya crypta. It inhibits viral DNA polymerase and DNA synthesis of herpes, vaccinica and varicella zoster viruses. However due to the discovery of new types of viruses and emergence of drug resistant strains, it is necessary to develop new antiviral lead compounds continuously. Several sponge derived antiviral lead compounds which are hoped to be developed as future drugs are discussed in this review. Supply problems are usually the major bottleneck to the development of these compounds as drugs during clinical trials. However advances in the field of metagenomics and high throughput microbial cultivation has raised the possibility that these techniques could lead to the cost-effective large scale production of such compounds. Perspectives on biotechnological methods with respect to marine drug development are also discussed.

Marine Sponges As a Drug Treasure

Bacteria from Marine Sponges: A Source of New Drugs

Bioactive Sesterterpenes and Triterpenes from Marine Sponges: Occurrence and Pharmacological Significance

Anticancer agents from marine sponges

Sponges-associated marine bacteria as sources of antimicrobial compounds

Chemical and biological diversity of new natural products from marine sponges: a review (2009–2018)

Antiviral lead compounds from marine sponges

Structurally Unprecedented Metabolites from Marine Sponges

Anti-inflammatory, anti-infectious and anti-cancer potential of marine algae and sponge: A review

Chemical and Biological Prospection of Marine Sponges Belonging to the Class Demospongiae: A Review

Bioactive Compounds from Marine Sponge Associates: Antibiotics from Bacillus Sp.

The Pharmacological Potential of Non-ribosomal Peptides from Marine Sponge and Tunicates

Marine actinobacteria as a drug treasure house

Spongia Sponges: Unabated Sources of Novel Secondary Metabolites

Marine Drugs from Sponge-Microbe Association—A Review

Recent Advances of Marine Sponge-Associated Microorganisms as a Source of Commercially Viable Natural Products

Anti-inflammatory Effects of Compounds Extracted from Marine Sponge s: A Systematic Review

Recent Advances on Marine Alkaloids from Sponges

A Review of Sponge-Derived Diterpenes: 2009–2022

Cytotoxic Natural Products from Marine Sponge-Derived Microorganisms

Progress in Studies on Secondary Metabolites of Sponges-Associated Microorganisms